As of 2025-05-17, the EV/EBITDA ratio of Covetrus Inc (CVET) is 23.2. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CVET's latest enterprise value is 3,903 mil USD. CVET's TTM EBITDA according to its financial statements is 168 mil USD. Dividing these 2 quantities gives us the above CVET EV/EBITDA ratio.
Range | Selected | |
Trailing EV/EBITDA multiples | 10.5x - 11.3x | 10.8x |
Forward EV/EBITDA multiples | 12.5x - 13.5x | 12.7x |
Fair Price | 2.19 - 6.66 | 4.19 |
Upside | -89.6% - -68.3% | -80.0% |
(USD in millions except Fair Price) | |||
Trailing | Forward | ||
Market Cap (USD mil) | EV/EBITDA | EV/EBITDA | |
Covetrus Inc | 2,941 | 23.2x | 38.6x |
Amerisourcebergen Corp | 36,150 | 10.4x | 13.7x |
Apria Inc | 1,337 | 6.8x | 6.7x |
Cardinal Health Inc | 37,262 | 13.2x | 7x |
Henry Schein Inc | 8,827 | 10.8x | 12.5x |
Mckesson Corp | 90,761 | 14.5x | 16.4x |
Owens & Minor Inc | 570 | 4.7x | 20.5x |
Patterson Companies Inc | 2,772 | 10.2x | 11.4x |
PetIQ Inc | 926 | 11.4x | 12.7x |
Industry median | 10.8x | 12.7x | |
(*) EBITDA | 168 | 101 | |
Enterprise value | 1,814 | 1,285 | |
(-) Net debt | 962 | 962 | |
Equity value | 852 | 323 | |
(/) Outstanding shares | 140 | 140 | |
Fair price | 6 | 2 | |